CTL-32764-05592
3 vaccinations
4 coded responses
13 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 038 / NH
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
- 2021-03-09
-
2021-03-14
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Headache, Pyrexia — Feeling: GoodFree text: I had slight fever, headache, tiredness the day after but felt good the next day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-16
- 2021-04-23
- 2021-05-04
-
2021-05-10
Survey response — day 35, dose 2MedDRA: Migraine, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Suffering from migraine clusters for the past week. These have been chronic yet cyclical at 4 years intervals.Also have an undiagnosed hip, pelvic groin and quadricep musculoskeletal pain probably unrelated to shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-15
-
2021-07-02
Survey response — 3 months, dose 2MedDRA: Cough, Nasal disorder, Nasopharyngitis, Office visit, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test negative, Viral infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Mild viral symptoms including low grade fever, head cold, sore throat, cough and nasal symptoms.Had negative COVID-19 and strep rapid tests at urgent care facility.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-01
-
2021-11-15
Dose 3 — Pfizer-BioNTech
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): No
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I had slight fever, headache, tiredness the day after but felt good the next day.
Release 8 — day 35, dose 2
Symptoms: Suffering from migraine clusters for the past week. These have been chronic yet cyclical at 4 years intervals.Also have an undiagnosed hip, pelvic groin and quadricep musculoskeletal pain probably unrelated to shot.
Release 9 — 3 months, dose 2
Symptoms: Mild viral symptoms including low grade fever, head cold, sore throat, cough and nasal symptoms.Had negative COVID-19 and strep rapid tests at urgent care facility.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nasal disorder | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Viral infection | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release